Tag

Teva Pharmaceutical

Coreg Patent Trial results in a $235 Million Win for GlaxoSmithKline from Teva Pharmaceuticals

Sticky post

A US jury recently ordered Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc $235 million ($234.1 million in lost profits and $1.4 million in royalties) for infringing a patent covering its blood pressure drug Coreg. A US federal jury found… Continue Reading →

© 2019 Dawn Ellmore Employment Blog — Powered by WordPress

Theme by Anders NorenUp ↑